✦ LIBER ✦

Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndrome

✍ Scribed by Kobayashi, Masafumi; Takahashi, Yuko; Yamashita, Hiroyuki; Kaneko, Hiroshi; Mimori, Akio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit and a possible risk of tocilizum

✍ Masafumi Kobayashi; Yuko Takahashi; Hiroyuki Yamashita; Hiroshi Kaneko; Akio Mim 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 201 KB

Reactive macrophage activation syndrome

✍ Banse, Christopher; Vittecoq, Olivier; Benhamou, Ygal; Gauthier-Prieur, Maud; Le 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 330 KB

Adult-onset Still’s disease with macroph

✍ Keisuke Maeshima; Koji Ishii; Mikako Iwakura; Misuzu Akamine; Hajime Hamasaki; I 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 282 KB